INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2012

Reishi mushroom as an adjunct to cancer therapy showed potential immune and response benefits

A meta-analysis of five randomized trials examined Ganoderma lucidum in cancer care. Combining the mushroom with chemotherapy or radiotherapy increased the likelihood of a positive response compared to conventional therapy alone (RR 1.50, 95% CI 0.90 to 2.51). Furthermore, supplementation raised CD3, CD4, and CD8 percentages by 3.91%, 3.05%, and 2.02%, while quality of life was relatively improved in four studies.

Study type
Meta-analysis of randomized controlled trials
Who was studied
Cancer patients across 5 randomized controlled trials
What was measured
Tumour response, host immune function, and quality of life

THE PAPER

Ganoderma lucidum (Reishi mushroom) for cancer treatment.

Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Cochrane Database Syst Rev, 2012.

PubMed 22696372 ↗DOI 10.1002/14651858.CD007731.pub2 ↗

CancerTop 21: Mushrooms

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.